Abivax SA • ABVX

Capital at risk.

About Abivax SA
Ticker
info
ABVX
Trading on
info
PA
ISIN
info
FR0012333284
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Marc M. P. de Garidel M.B.A.
Headquarters
info
7-11 Boulevard Haussmann, Paris, undefined, France, 75009
Employees
info
80
Website
info
abivax.com
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Metrics
BasicAdvanced
Market cap
info
€6.78B
P/E ratio
info
-
EPS
info
-€4.61
Dividend Yield
info
0.00%
Beta
info
-0.2
Forward P/E ratio
info
1
EBIDTA
info
€-254M
Ex dividend date
info
-
Price & volume
Market cap
info
€6.78B
Average daily volume
info
0.6M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
€0.00
Dividend yield
info
0.00%
Forward dividend per share
info
€0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
1
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
1,378.95
Price to book
info
15.79
Earnings
EPS
info
-€4.61
EPS estimate (current quarter)
info
-€0.85
EPS estimate (next quarter)
info
-€0.89
EBITDA
info
€-254M
Revenues (TTM)
info
€4.9M
Revenues per share (TTM)
info
€0.07
Technicals
Beta
info
-0.2
52-week High
info
€132.00
52-week Low
info
€5.12
50-day moving average
info
€99.50
200-day moving average
info
€96.00
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
-157.07%
ROA (TTM)
info
-44.65%
Profit margin
info
0.00%
Gross profit margin
info
€4.9M
Operating margin
info
-4,183.71%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
35.20%
Share stats
Outstanding Shares
info
79.8M
Float
info
58.2M
Insiders %
info
5.30%
Institutions %
info
50.81%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-€0.76
-€0.70
-9.01%
Q2 • 25Missed
-€2.10
-€0.63
-233.71%
Q3 • 25Missed
-€2.66
-€0.98
-171.43%
Q4 • 25Missed
-€0.61
-€0.85
28.24%
Q1 • 26Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
€-2M
€-235M
11,666.73%
Q4 • 25
€0M
€-48.5M
-∞%
Q1 • 26
-100.00%
-79.40%
-∞%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
€584M
€129M
22.10%
Q4 • 25
€547M
€118M
21.48%
Q1 • 26
-6.37%
-8.97%
-2.78%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
€-71.3M
-
€603M
€-95.6M
Q4 • 25
€-50.5M
€0M
€0.1M
€-50.6M
Q1 • 26
-29.13%
-
-99.99%
-47.07%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Abivax SA share?
Collapse

Abivax SA shares are currently traded for undefined per share.

How many shares does Abivax SA have?
Collapse

Abivax SA currently has 79.8M shares.

Does Abivax SA pay dividends?
Collapse

No, Abivax SA doesn't pay dividends.

What is Abivax SA 52 week high?
Collapse

Abivax SA 52 week high is €132.00.

What is Abivax SA 52 week low?
Collapse

Abivax SA 52 week low is €5.12.

What is the 200-day moving average of Abivax SA?
Collapse

Abivax SA 200-day moving average is €96.00.

Who is Abivax SA CEO?
Collapse

The CEO of Abivax SA is Marc M. P. de Garidel M.B.A..

How many employees Abivax SA has?
Collapse

Abivax SA has 80 employees.

What is the market cap of Abivax SA?
Collapse

The market cap of Abivax SA is €6.78B.

What is the P/E of Abivax SA?
Collapse

The current P/E of Abivax SA is null.

What is the EPS of Abivax SA?
Collapse

The EPS of Abivax SA is -€4.61.

What is the PEG Ratio of Abivax SA?
Collapse

The PEG Ratio of Abivax SA is null.